Cargando…

Characteristics and differences of gut microbiota in patients with different Traditional Chinese Medicine Syndromes of Colorectal Cancer and normal population

Colorectal cancer (CRC) is considered to be closely associated with alteration of intestinal microorganisms. The purpose of present study was to investigate the distribution of gut microbiota in the distinction of microbiota dysbiosis between two disease syndromes called Zheng-Qi-Kui-Xu(ZQKX) and Xi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Peipei, Ding, Shuning, Sun, Leitao, Feng, Yuqian, Guo, Kaibo, Zhu, Ying, Huang, Dawei, Ruan, Shanming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646174/ https://www.ncbi.nlm.nih.gov/pubmed/33193900 http://dx.doi.org/10.7150/jca.50318

Ejemplares similares

Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor
por: Shan, Feiyu, et al.
Publicado: (2020)

Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
por: Guo, Kaibo, et al.
Publicado: (2020)

Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study
por: Feng, Yuqian, et al.
Publicado: (2021)

Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
por: Li, Jinfan, et al.
Publicado: (2023)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
por: Guo, Kaibo, et al.
Publicado: (2021)

Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma
por: Jin, Huimin, et al.
Publicado: (2020)

Corrigendum: Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma
por: Jin, Huimin, et al.
Publicado: (2021)

An overview of traditional Chinese medicine affecting gut microbiota in obesity
por: Li, Donghui, et al.
Publicado: (2023)

Transcription factor POU4F2 promotes colorectal cancer cell migration and invasion through hedgehog‐mediated epithelial‐mesenchymal transition
por: Guo, Kaibo, et al.
Publicado: (2021)

The new exploration of pure total flavonoids extracted from Citrus maxima (Burm.) Merr. as a new therapeutic agent to bring health benefits for people
por: Ding, Shuning, et al.
Publicado: (2022)

Traditional Chinese medicine against COVID-19: Role of the gut microbiota
por: Yang, Zhihua, et al.
Publicado: (2022)

The difference of human gut microbiome in colorectal cancer with and without metastases
por: Sun, Leitao, et al.
Publicado: (2022)

Risk factors for in-hospital mortality in patients with cancer and COVID-19
por: Guo, Kaibo, et al.
Publicado: (2020)

Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis
por: Yan, Qingying, et al.
Publicado: (2018)

Right- and left-sided colorectal cancers respond differently to traditional Chinese medicine
por: Liu, Shan-Shan, et al.
Publicado: (2017)

Traditional Chinese Medicine Alleviates Ulcerative Colitis via Modulating Gut Microbiota
por: Feng, Wan, et al.
Publicado: (2022)

Effect of Traditional Chinese Medicine on the Gut Microbiota in Heat-Stressed Laying Hens
por: Ye, Chunxin, et al.
Publicado: (2022)

Interaction of gut microbiota with the tumor microenvironment: A new strategy for antitumor treatment and traditional Chinese medicine in colorectal cancer
por: Li, Tingting, et al.
Publicado: (2023)

Metagenomic Analysis of Gut Microbiome in Gout Patients with Different Chinese Traditional Medicine Treatments
por: Xie, Jingjing, et al.
Publicado: (2022)

Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy
por: Zhang, Bo, et al.
Publicado: (2020)

Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis
por: Du, Wurong, et al.
Publicado: (2022)

A Predictive Nomogram for Early Mortality in Stage IV Gastric Cancer
por: Feng, Yuqian, et al.
Publicado: (2020)

The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends
por: Yang, Shanshan, et al.
Publicado: (2022)

The Role of Gut Microbiota in the Progression of Parkinson’s Disease and the Mechanism of Intervention by Traditional Chinese Medicine
por: Huan, Pengfei, et al.
Publicado: (2022)

Gut microbiota, a hidden protagonist of traditional Chinese medicine for acute ischemic stroke
por: Gao, Lin, et al.
Publicado: (2023)

Prevention and treatment of rheumatoid arthritis through traditional Chinese medicine: role of the gut microbiota
por: Liang, Yujiao, et al.
Publicado: (2023)

Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian Cancer
por: Tao, Fangfang, et al.
Publicado: (2016)

Gut brain interaction theory reveals gut microbiota mediated neurogenesis and traditional Chinese medicine research strategies
por: Zhang, Chenxi, et al.
Publicado: (2022)

Is Traditional Chinese Medicine “Mainstream” in China? Trends in Traditional Chinese Medicine Health Resources and Their Utilization in Traditional Chinese Medicine Hospitals from 2004 to 2016
por: Shi, Xuefeng, et al.
Publicado: (2020)

What Causes Death in Esophageal Cancer Patients Other Than the Cancer Itself: A Large Population-Based Analysis
por: Zheng, Xueer, et al.
Publicado: (2022)

Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis
por: Zhang, Ya-Li, et al.
Publicado: (2019)

Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease
por: Cheng, Tian-Yi, et al.
Publicado: (2021)

Influence of Dietary Components and Traditional Chinese Medicine on Hypertension: A Potential Role for Gut Microbiota
por: Zhang, Guo-Xin, et al.
Publicado: (2021)

Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
por: Zhu, Li-Ran, et al.
Publicado: (2023)

Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Breast Invasive Ductal Carcinoma Patients After Surgery: A Large Population-Based Study
por: Feng, Yuqian, et al.
Publicado: (2022)

The prognostic value of 4.1 mRNA expression in non-small cell lung cancer
por: Xiang, Yuying, et al.
Publicado: (2021)

Taxus wallichiana var. chinensis (Pilg.) Florin Aqueous Extract Suppresses the Proliferation and Metastasis in Lung Carcinoma via JAK/STAT3 Signaling Pathway
por: Sun, Leitao, et al.
Publicado: (2021)

HIT000218960 promotes gastric cancer cell proliferation and migration through upregulation of HMGA2 expression
por: Sun, Leitao, et al.
Publicado: (2019)

The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota
por: Ji, Wenyan, et al.
Publicado: (2020)

New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes
por: Chen, Yanxia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kqpudencm2uh2eqigoal8ufopp